Expression of hBD-1 mRNA and peptide were significantly reduced in basal cell carcinoma (BCC) of the skin (20) and in cutaneous squamous cell carcinoma (SCC), as compared to healthy skin and precursor lesions (21), and in colon cancer (23). The gene discussed is DEFB1; the disease is malignant colon neoplasm.